1-4 of 4
Kingo Fujimura, MD, PhD
Close
Sort by
Journal Articles

Rituximab As Second-Line Treatment For Chronic Immune Thrombocytopenia: Investigator-Initiated Clinical Trial In Japan

Yoshitaka Miyakawa, MD, PhD, Shinya Katsutani, MD, PhD, Takahiro Yano, MD, PhD, Shosaku Nomura, MD, PhD, Kaichi Nishiwaki, MD, Yoshiaki Tomiyama, MD, PhD, Masaaki Higashihara, MD, PhD, Yukari Shirasugi, MD, PhD, Masakatsu Nishikawa, MD, PhD, Katsutoshi Ozaki, MD, PhD, Kayoko Kikuchi, Takayuki Abe, PhD, Yuji Sato, MD, PhD, Yuzuru Kanakura, Kingo Fujimura, MD, PhD, Yasuo Ikeda, MD, PhD, Shinichiro Okamoto, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3554.
https://doi.org/10.1182/blood.V122.21.3554.3554
Published: 2013
Journal Articles

Prevalence and Cause of Death in Patients with Monoclonal Gammopathy in Atomic Bomb Survivors in Hiroshima

Kingo Fujimura, MD, PhD, Fumiyoshi Kasagi, Ph.D, Hideo Sasaki, M.D., Ph.D, Chikako Ito, M.D., Ph.D
Journal: Blood
Blood (2008) 112 (11): 2714.
https://doi.org/10.1182/blood.V112.11.2714.2714
Published: 2008
Journal Articles

Mutations of the SBDS Gene Result in Nuclear Mislocalization.

Masafumi Yamaguchi, PhD, Kingo Fujimura, MD, PhD, Hanae Toga-Yamaguchi, Valentina Svetic, PhD, Naoki Okamura, PhD, Rajesh Chopra, PhD
Journal: Blood
Blood (2008) 112 (11): 2034.
https://doi.org/10.1182/blood.V112.11.2034.2034
Published: 2008
Journal Articles

The SBDS Gene Regulates Viability of Myeloid Precursor Cells and Is Associated with High ROS Production and Telomere Shortening in the SBDS Downregulated Cells.

Masafumi Yamaguchi, PhD, Kingo Fujimura, MD,PhD, Hanae Toga, Asim Khwaja, MD, Naoki Okamura, PhD, Rajesh Chopra, MD
Journal: Blood
Blood (2006) 108 (11): 1639.
https://doi.org/10.1182/blood.V108.11.1639.1639
Published: 2006